- Home
- RPAY vs RAPP Comparison
RPAY vs RAPP Comparison
Compare RPAY & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPAY
- RAPP
- Stock Information
- Founded
- RPAY 2006
- RAPP 2022
- Country
- RPAY United States
- RAPP United States
- Employees
- RPAY N/A
- RAPP N/A
- Industry
- RPAY Business Services
- RAPP
- Sector
- RPAY Consumer Discretionary
- RAPP
- Exchange
- RPAY Nasdaq
- RAPP Nasdaq
- Market Cap
- RPAY 467.5M
- RAPP 439.4M
- IPO Year
- RPAY N/A
- RAPP 2024
- Fundamental
- Price
- RPAY $4.83
- RAPP $14.15
- Analyst Decision
- RPAY Buy
- RAPP Strong Buy
- Analyst Count
- RPAY 9
- RAPP 2
- Target Price
- RPAY $8.06
- RAPP $35.00
- AVG Volume (30 Days)
- RPAY 912.6K
- RAPP 161.7K
- Earning Date
- RPAY 08-11-2025
- RAPP 08-11-2025
- Dividend Yield
- RPAY N/A
- RAPP N/A
- EPS Growth
- RPAY N/A
- RAPP N/A
- EPS
- RPAY N/A
- RAPP N/A
- Revenue
- RPAY $309,647,000.00
- RAPP N/A
- Revenue This Year
- RPAY N/A
- RAPP N/A
- Revenue Next Year
- RPAY $8.07
- RAPP N/A
- P/E Ratio
- RPAY N/A
- RAPP N/A
- Revenue Growth
- RPAY 2.26
- RAPP N/A
- 52 Week Low
- RPAY $3.59
- RAPP $6.43
- 52 Week High
- RPAY $9.75
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- RPAY 45.19
- RAPP N/A
- Support Level
- RPAY $5.11
- RAPP N/A
- Resistance Level
- RPAY $5.55
- RAPP N/A
- Average True Range (ATR)
- RPAY 0.21
- RAPP 0.00
- MACD
- RPAY -0.03
- RAPP 0.00
- Stochastic Oscillator
- RPAY 21.43
- RAPP 0.00
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.